This study identifies the main research hotspots in refractory asthma, including clinical and epidemiological aspects, immunological mechanisms, and biologic therapies and clinical trials. Future trends in refractory asthma research emphasize guideline-informed precision medicine, integrating biomarkers, digital tools, and individualized treatment strategies to enhance care standardization and effectiveness.
Xu et al. (2026) studied this question.